以辛伐他汀为对照,研究调脂胶囊连续灌胃3周对实验性血脂代谢紊乱大鼠血脂的调节作用。结果表明,调脂胶囊大、中、小剂量[10 g、5 g、2.5 g/(Kg*d)]均极显著降低血脂代谢紊乱大鼠血清TC和LDL-C值(P<0.001),其作用均较大剂量辛伐他汀稍强,并显著升高HDL-C、HDL-C/TC值(P<0.05);大、中剂量均极显著降低TG值(P<0.01),与辛伐他汀作用相当。研究结果表明,该胶囊对大鼠血脂代谢紊乱有很好的调节作用,其有效剂量范围较大,中等剂量调脂作用与大剂量辛伐他汀作用基本相当。%The role of lipid-regulating capsule in the regulation of experimental dislipidemia was studied in SD rats. The SD rats were divided into 6 groups: group A (normal control),group B to F (experimental hyperlipidemia). The rats in the groups C,D and E received the capsule in a daily dose of 2.5 g,5 g and 10 g/kg respectively for 3 weeks,while the rats in the group F received Simvastatin in a daily dose of 7.5 mg/kg for 3 weeks. By comparison with the group B after 3 weeks,the levels of plasma total cholesterol (TC) and low density lipoprotein (LDL-C) were very significantly decreased in the groups C,D,E and F(P<0.01),the value of plasma total triglyceride (TG) was very significantly decreased in the groups D,E and F (<0.01),and the level of high density lipoprotein was significantly increased in the groups C,D and E (P<0.05),but very significantly increased in the group F (P<0.01). It was suggested that the therapeutic efficiency of the lipid-regulating capsule in low,middle and high dosage was the same as that in high dose of simvastatin for the SD rats with high plasma TC and LDL-C,and middle and high doses of the capsule had the same effect of simvastatin on the plasma TG.
展开▼